An achievement of the Work Package 3 for IMAGIO – SIOPE
SIOPE shared a post by IMAGIO Project on LinkedIn, adding:
“Exciting News Alert for cross-border innovation!
The beginning of the year marks an achievement of the Work Package 3 (WP3) for IMAGIO!
At the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano in Italy, the first patient has been enroled in the project!
As IMAGIO proposes a patient-centred approach, the tumour removal process is optimised, and the damage to healthy tissue is minimised with the range of less invasive and more efficient treatment options.
Learn more about IMAGIO’s progress here.”
Quoting IMAGIO Project‘s post:
“We are happy to announce the enrolment of our first patient at the Fondazione IRCCS Istituto Nazionale dei Tumori di Milano in Italy, a significant step forward in our project.
This achievement is part of Work Package 3 (WP3), which focuses on combining advanced imaging and therapeutic technologies to optimise and standardise liver tumor ablation.
Why is this important?
Multimodal ablation therapy offers a revolutionary approach to liver cancer treatment, aiming to:
– Optimise tumour removal while minimising damage to healthy tissue.
– Provide patients with less invasive, more effective treatment options.
The collaboration of these European centres highlights IMAGIO’s dedication to cross-border innovation and patient-centred healthcare advancements. With clinical trials progressing in Italy and the Netherlands, IMAGIO is on track to deliver transformative technologies that will shape the future of liver cancer care.
Read more about our progress.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023